Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mariska A. M. Schröder"'
Autor:
Bas P. H. Adriaansen, Agustini Utari, Dineke Westra, Achmad Zulfa Juniarto, Mahayu Dewi Ariani, Annastasia Ediati, Mariska A. M. Schröder, Paul N. Span, Fred C. G. J. Sweep, Stenvert L. S. Drop, Sultana M. H. Faradz, Antonius E. van Herwaarden, Hedi L. Claahsen – van der Grinten
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionCongenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) or 11-hydroxylase deficiency (11OHD) is characterized by underproduction of cortisol and overproduction of adrenal androgens. These androgens lead to a variable
Externí odkaz:
https://doaj.org/article/48f6cb3fd87c455992e4f56a2d178f4c
Autor:
Bas P. H. Adriaansen, Mariska A. M. Schröder, Paul N. Span, Fred C. G. J. Sweep, Antonius E. van Herwaarden, Hedi L. Claahsen-van der Grinten
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Congenital adrenal hyperplasia (CAH) due to 21α-hydroxylase deficiency (21OHD) or 11β-hydroxylase deficiency (11OHD) are congenital conditions with affected adrenal steroidogenesis. Patients with classic 21OHD and 11OHD have a (nearly) complete enz
Externí odkaz:
https://doaj.org/article/98e97c9d76e5434592ee3066ad8017d6
Autor:
Mariska A M Schröder, Fred C G J Sweep, Antonius E van Herwaarden, Rod T Mitchell, Jitske Eliveld, Ans M M van Pelt, Alan E Rowan, Darren Korbie, Nike M M L Stikkelbroeck, Hedi L Claahsen-van der Grinten, Paul N Span
Publikováno v:
European Journal of Endocrinology, 187, 607-615
European Journal of Endocrinology, 187(5), 607-615. BioScientifica Ltd.
European Journal of Endocrinology, 187, 5, pp. 607-615
Schröder, M A M, Sweep, F C G J, Van Herwaarden, A E, Mitchell, R T, Eliveld, J, Van Pelt, A M M, Rowan, A E, Korbie, D, Stikkelbroeck, N M M L, Claahsen-van Der Grinten, H L & Span, P N 2022, ' Transcriptional comparison of Testicular Adrenal Rest Tumors with fetal and adult tissues ', European Journal of Endocrinology . https://doi.org/10.1530/EJE-22-0143
European Journal of Endocrinology, 187(5), 607-615. BioScientifica Ltd.
European Journal of Endocrinology, 187, 5, pp. 607-615
Schröder, M A M, Sweep, F C G J, Van Herwaarden, A E, Mitchell, R T, Eliveld, J, Van Pelt, A M M, Rowan, A E, Korbie, D, Stikkelbroeck, N M M L, Claahsen-van Der Grinten, H L & Span, P N 2022, ' Transcriptional comparison of Testicular Adrenal Rest Tumors with fetal and adult tissues ', European Journal of Endocrinology . https://doi.org/10.1530/EJE-22-0143
Background Testicular adrenal rest tumors (TART) are a common complication of unknown cellular origin in patients with congenital adrenal hyperplasia (CAH). These benign tumors have both adrenal and testicular characteristics and are hypothesized to
Publikováno v:
Reviews in endocrinemetabolic disorders. 23(3)
Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) need life-long medical treatment to replace the lacking glucocorticoids and potentially lacking mineralocorticoids and to lower elevated adrenal androgens.
Autor:
Paul N. Span, Antonius E. van Herwaarden, Patrick O’Day, Hedi L Claahsen-van der Grinten, Fred C. G. J. Sweep, Richard J. Auchus, Adina F. Turcu, Mariska A M Schröder
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 107, 1, pp. e272-e280
Journal of Clinical Endocrinology and Metabolism, 107, e272-e280
The Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, 107, e272-e280
The Journal of Clinical Endocrinology and Metabolism
Context Testicular adrenal rest tumors (TART) are a common complication in males with classic 21-hydroxylase deficiency (21OHD). TART are likely to contribute to the androgen excess in 21OHD patients, but a direct quantification of steroidogenesis fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5cf67406b3f5b2722c99a12d87dbced
https://repository.ubn.ru.nl/handle/2066/242588
https://repository.ubn.ru.nl/handle/2066/242588
Autor:
Bas P. H. Adriaansen, Johannes S. Kamphuis, Mariska A. M. Schröder, André J. Olthaar, Carina Bock, André Brandt, Nike M. M. L. Stikkelbroeck, Eef G. W. M. Lentjes, Paul N. Span, Fred C. G. J. Sweep, Hedi L. Claahsen‐van der Grinten, Antonius E. van Herwaarden
Publikováno v:
Clinical Endocrinology, 97, 36-42
Clinical Endocrinology, 97, 1, pp. 36-42
Clinical Endocrinology, 97, 1, pp. 36-42
Contains fulltext : 251424.pdf (Publisher’s version ) (Open Access) OBJECTIVE: Treatment of congenital adrenal hyperplasia (CAH) patients with glucocorticoids is often challenging since there is a delicate balance between over- and undertreatment.
Autor:
Antonius E. van Herwaarden, Gianni Bocca, Sabine E. Hannema, Dina A. Schott, Erica L T van den Akker, Paul N. Span, Hedi L Claahsen-van der Grinten, Hetty J. van der Kamp, Fred C.G.J. Sweep, Janiëlle A E M van der Velden, Christiaan F. Mooij, Mariska A M Schröder, Saartje Straetemans, Sandra W.K. de Kort, Vera van Tellingen
Publikováno v:
Schroder, M A M, van Herwaarden, A E, Span, P N, van den Akker, E L T, Bocca, G, Hannema, S E, van der Kamp, H J, de Kort, S W K, Mooij, C F, Schott, D A, Straetemans, S, Van Tellingen, V, van der Velden, J A, Sweep, F C G J & Grinten, H L C D 2021, ' Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency ', Hormone Research in Paediatrics, vol. 94, no. SUPPL 1, pp. 63-64 .
Hormone Research in Paediatrics, 94(SUPPL 1), 63-64. S. Karger AG
Journal of Clinical Endocrinology and Metabolism, 107(4), E1661-E1672. The Endocrine Society
Schröder, M A M, Van Herwaarden, A E, Span, P N, Van Den Akker, E L T, Bocca, G, Hannema, S E, Van Der Kamp, H J, De Kort, S W K, Mooij, C F, Schott, D A, Straetemans, S, Van Tellingen, V, Van Der Velden, J A, Sweep, F C G J & Claahsen-Van Der Grinten, H L 2022, ' Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency ', Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 4, pp. E1661-E1672 . https://doi.org/10.1210/clinem/dgab826
Journal of Clinical Endocrinology and Metabolism, 107, E1661-E1672
Journal of Clinical Endocrinology and Metabolism, 107, 4, pp. E1661-E1672
Schröder, M A M, van Herwaarden, A E, Span, P N, van den Akker, E L T, Bocca, G, Hannema, S E, van der Kamp, H J, de Kort, S W K, Mooij, C F, Schott, D A, Straetemans, S, van Tellingen, V, van der Velden, J A, Sweep, F C G J & van der Grinten, H L C 2021, ' Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency ', The Journal of clinical endocrinology and metabolism . https://doi.org/10.1210/clinem/dgab826
The Journal of clinical endocrinology and metabolism. The Endocrine Society
Journal of clinical endocrinology and metabolism, 107(4), E1661-E1672. The Endocrine Society
Journal of Clinical Endocrinology & Metabolism, 107(4), E1661-E1672. ENDOCRINE SOC
Journal of Clinical Endocrinology & Metabolism, 107(4), E1661-E1672. Oxford University Press
Journal of Clinical Endocrinology and Metabolism, 107(4), E1661-E1672. Endocrine Society
Hormone Research in Paediatrics, 94(SUPPL 1), 63-64. S. Karger AG
Journal of Clinical Endocrinology and Metabolism, 107(4), E1661-E1672. The Endocrine Society
Schröder, M A M, Van Herwaarden, A E, Span, P N, Van Den Akker, E L T, Bocca, G, Hannema, S E, Van Der Kamp, H J, De Kort, S W K, Mooij, C F, Schott, D A, Straetemans, S, Van Tellingen, V, Van Der Velden, J A, Sweep, F C G J & Claahsen-Van Der Grinten, H L 2022, ' Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency ', Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 4, pp. E1661-E1672 . https://doi.org/10.1210/clinem/dgab826
Journal of Clinical Endocrinology and Metabolism, 107, E1661-E1672
Journal of Clinical Endocrinology and Metabolism, 107, 4, pp. E1661-E1672
Schröder, M A M, van Herwaarden, A E, Span, P N, van den Akker, E L T, Bocca, G, Hannema, S E, van der Kamp, H J, de Kort, S W K, Mooij, C F, Schott, D A, Straetemans, S, van Tellingen, V, van der Velden, J A, Sweep, F C G J & van der Grinten, H L C 2021, ' Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency ', The Journal of clinical endocrinology and metabolism . https://doi.org/10.1210/clinem/dgab826
The Journal of clinical endocrinology and metabolism. The Endocrine Society
Journal of clinical endocrinology and metabolism, 107(4), E1661-E1672. The Endocrine Society
Journal of Clinical Endocrinology & Metabolism, 107(4), E1661-E1672. ENDOCRINE SOC
Journal of Clinical Endocrinology & Metabolism, 107(4), E1661-E1672. Oxford University Press
Journal of Clinical Endocrinology and Metabolism, 107(4), E1661-E1672. Endocrine Society
Context Hydrocortisone treatment of young patients with 21-hydroxylase deficiency (21OHD) is given thrice daily, but there is debate about the optimal timing of the highest hydrocortisone dose, either mimicking the physiological diurnal rhythm (morni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6cade1ce4b17d153caec8b6b27afbce
https://research.vumc.nl/en/publications/8ffc5d4b-b9b2-4d48-be26-611f54a31d24
https://research.vumc.nl/en/publications/8ffc5d4b-b9b2-4d48-be26-611f54a31d24
Autor:
Fred C. G. J. Sweep, Paul N. Span, Adina F. Turcu, Mariska A M Schröder, Hedi L Claahsen-van der Grinten, Antonius E. van Herwaarden, Richard J. Auchus, Patrick O’Day
Publikováno v:
Journal of the Endocrine Society
Context Testicular adrenal rest tumors (TART) are a common complication in males with classic 21-hydroxylase deficiency (21OHD). TART are likely to contribute to the androgen excess in 21OHD patients, but a direct quantification of steroidogenesis fr